These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28080056)

  • 21. Characterizing Drug-Target Residence Time with Metadynamics: How To Achieve Dissociation Rate Efficiently without Losing Accuracy against Time-Consuming Approaches.
    Sun H; Li Y; Shen M; Li D; Kang Y; Hou T
    J Chem Inf Model; 2017 Aug; 57(8):1895-1906. PubMed ID: 28749138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of Drug-Target Residence Time by Targeted Molecular Dynamics Simulations.
    Ziada S; Diharce J; Raimbaud E; Aci-Sèche S; Ducrot P; Bonnet P
    J Chem Inf Model; 2022 Nov; 62(22):5536-5549. PubMed ID: 36350238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Conformational Flexibility on Binding Free Energy Estimation between Kinases and Their Inhibitors.
    Araki M; Kamiya N; Sato M; Nakatsui M; Hirokawa T; Okuno Y
    J Chem Inf Model; 2016 Dec; 56(12):2445-2456. PubMed ID: 28024406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of potent and selective CDK8 inhibitors through FBDD approach.
    Han X; Jiang M; Zhou C; Zhou Z; Xu Z; Wang L; Mayweg AV; Niu R; Jin TG; Yang S
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4488-4492. PubMed ID: 28802632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decoding the Role of Water Dynamics in Ligand-Protein Unbinding: CRF1R as a Test Case.
    Bortolato A; Deflorian F; Weiss DR; Mason JS
    J Chem Inf Model; 2015 Sep; 55(9):1857-66. PubMed ID: 26335976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of protein-ligand affinity prediction using steered molecular dynamics simulations.
    Okimoto N; Suenaga A; Taiji M
    J Biomol Struct Dyn; 2017 Nov; 35(15):3221-3231. PubMed ID: 27771988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerating the Calculation of Protein-Ligand Binding Free Energy and Residence Times Using Dynamically Optimized Collective Variables.
    Brotzakis ZF; Limongelli V; Parrinello M
    J Chem Theory Comput; 2019 Jan; 15(1):743-750. PubMed ID: 30537822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations.
    Galvani F; Pala D; Cuzzolin A; Scalvini L; Lodola A; Mor M; Rizzi A
    J Chem Inf Model; 2023 May; 63(9):2842-2856. PubMed ID: 37053454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of Threonine-Tyrosine Kinase Receptor-Ligand Unbinding Kinetics with Multiscale Milestoning and Metadynamics.
    Votapka LW; Ojha AA; Asada N; Amaro RE
    J Phys Chem Lett; 2024 Oct; 15(42):10473-10478. PubMed ID: 39392497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational free energy modeling of druglike molecules by metadynamics in the WHIM space.
    Spiwok V; Hlat-Glembová K; Tvaroška I; Králová B
    J Chem Inf Model; 2012 Mar; 52(3):804-13. PubMed ID: 22360151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transition-Tempered Metadynamics Is a Promising Tool for Studying the Permeation of Drug-like Molecules through Membranes.
    Sun R; Dama JF; Tan JS; Rose JP; Voth GA
    J Chem Theory Comput; 2016 Oct; 12(10):5157-5169. PubMed ID: 27598403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Dynamics Analysis of Binding of Kinase Inhibitors to WT EGFR and the T790M Mutant.
    Park J; McDonald JJ; Petter RC; Houk KN
    J Chem Theory Comput; 2016 Apr; 12(4):2066-78. PubMed ID: 27010480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of Drug Binding and Residence Time.
    Bernetti M; Masetti M; Rocchia W; Cavalli A
    Annu Rev Phys Chem; 2019 Jun; 70():143-171. PubMed ID: 30786217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unbiased Molecular Dynamics of 11 min Timescale Drug Unbinding Reveals Transition State Stabilizing Interactions.
    Lotz SD; Dickson A
    J Am Chem Soc; 2018 Jan; 140(2):618-628. PubMed ID: 29303257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Molecular Dynamics and Related Methods in Drug Discovery.
    De Vivo M; Masetti M; Bottegoni G; Cavalli A
    J Med Chem; 2016 May; 59(9):4035-61. PubMed ID: 26807648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-kinetic relationship study of CDK8/CycC specific compounds.
    Schneider EV; Böttcher J; Huber R; Maskos K; Neumann L
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8081-6. PubMed ID: 23630251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free-energy-based methods for binding profile determination in a congeneric series of CDK2 inhibitors.
    Fidelak J; Juraszek J; Branduardi D; Bianciotto M; Gervasio FL
    J Phys Chem B; 2010 Jul; 114(29):9516-24. PubMed ID: 20593892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional kinases: Less is more (or less).
    Boyer TG
    Nat Chem Biol; 2016 Jan; 12(1):4-5. PubMed ID: 26678610
    [No Abstract]   [Full Text] [Related]  

  • 40. Activation of Abl1 Kinase Explored Using Well-Tempered Metadynamics Simulations on an Essential Dynamics Sampled Path.
    Oruganti B; Friedman R
    J Chem Theory Comput; 2021 Nov; 17(11):7260-7270. PubMed ID: 34647743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.